A program for treating olanzapine-related weight gain

被引:113
作者
Ball, MP [1 ]
Coons, VB [1 ]
Buchanan, RW [1 ]
机构
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA
关键词
D O I
10.1176/appi.ps.52.7.967
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study evaluated the effectiveness of a Weight Watchers program for patients with schizophrenia who had olanzapine-related weight gain and ascertained whether the severity of patients' psychiatric symptoms was correlated with the patients' success in losing weight. Seven men and four women who had been treated with olanzapine and who had gained at least 7 percent of their pretreatment body weight attended Weight Watchers meetings and were offered supervised exercise sessions. The patients' weight, body mass index, and psychiatric symptoms were assessed and were compared with those of a matched comparison group who did not attend the Weight Watchers program. Only the men experienced significant weight loss. No correlation was found between weight loss and exercise or change in psychiatric symptoms.
引用
收藏
页码:967 / 969
页数:3
相关论文
共 5 条
[1]   Body weight gain induced by antipsychotic drugs: mechanisms and management [J].
Baptista, T .
ACTA PSYCHIATRICA SCANDINAVICA, 1999, 100 (01) :3-16
[2]  
Ganguli R, 1999, J CLIN PSYCHIAT, V60, P20
[3]  
GOLDMAN LS, 1999, JCP VISUALS, V1, P3
[4]   DRUG-INDUCED WEIGHT-GAIN [J].
KALUCY, RS .
DRUGS, 1980, 19 (04) :268-278
[5]   WEIGHT-GAIN ASSOCIATED WITH NEUROLEPTIC MEDICATION - A REVIEW [J].
STANTON, JM .
SCHIZOPHRENIA BULLETIN, 1995, 21 (03) :463-472